Biolife Solutions Inc. Files SEC Form 4, Statement of Changes in Beneficial Ownership of Securities: (May 17, 2024).
In: Health & Medicine Week, 2024-06-07, S. 10420-10420
serialPeriodical
Zugriff:
Biolife Solutions Inc., a company in the electromedical and electrotherapeutic apparatus industry, filed a Form 4 with the U.S. Securities and Exchange Commission (SEC) on May 17, 2024. The Form 4 is a statement of changes in beneficial ownership of securities and is required for directors, officers, and owners of more than ten percent of a class of equity securities. The filing contains information about the reporting person's relationship to the company and any purchases or sales of equity securities. For more information, the SEC filing can be found at the provided link. [Extracted from the article]
Copyright of Health & Medicine Week is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Titel: |
Biolife Solutions Inc. Files SEC Form 4, Statement of Changes in Beneficial Ownership of Securities: (May 17, 2024).
|
---|---|
Zeitschrift: | Health & Medicine Week, 2024-06-07, S. 10420-10420 |
Veröffentlichung: | 2024 |
Medientyp: | serialPeriodical |
ISSN: | 1531-6459 (print) |
Sonstiges: |
|